2160 — MicroPort CardioFlow Medtech Cashflow Statement
0.000.00%
Last trade - 00:00- HK$3.02bn
- HK$3.43bn
- $57.04m
Annual cashflow statement for MicroPort CardioFlow Medtech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | IFRS | IFRS | IFRS | — | — |
| Status: | fx Final | fx Final | fx Final | fx Final | fx Preliminary |
| Net Income/Starting Line | -28.3 | -67.1 | -65.5 | -6.43 | — |
| Depreciation | |||||
| Non-Cash Items | 3.79 | 25.3 | 25.1 | -9.51 | — |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -7.39 | 3.07 | 0.745 | -11.7 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -25 | -27.1 | -29.2 | -15.5 | — |
| Capital Expenditures | -16.8 | -7.29 | -4.31 | -22 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -51 | -19.4 | -79.9 | -89 | — |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -67.8 | -26.7 | -84.2 | -111 | — |
| Financing Cash Flow Items | -0.47 | 0.162 | -0.067 | -0.525 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 345 | -20.3 | -3.62 | -7.83 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 248 | -51.3 | -113 | -133 | — |